首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   28278篇
  免费   2561篇
  国内免费   3888篇
  34727篇
  2024年   107篇
  2023年   447篇
  2022年   951篇
  2021年   1586篇
  2020年   1113篇
  2019年   1407篇
  2018年   1280篇
  2017年   964篇
  2016年   1225篇
  2015年   1860篇
  2014年   2276篇
  2013年   2371篇
  2012年   2877篇
  2011年   2500篇
  2010年   1635篇
  2009年   1528篇
  2008年   1649篇
  2007年   1497篇
  2006年   1252篇
  2005年   1119篇
  2004年   889篇
  2003年   810篇
  2002年   658篇
  2001年   441篇
  2000年   354篇
  1999年   367篇
  1998年   252篇
  1997年   200篇
  1996年   190篇
  1995年   152篇
  1994年   133篇
  1993年   91篇
  1992年   96篇
  1991年   86篇
  1990年   69篇
  1989年   62篇
  1988年   54篇
  1987年   35篇
  1986年   34篇
  1985年   44篇
  1984年   13篇
  1983年   15篇
  1982年   12篇
  1981年   11篇
  1980年   3篇
  1979年   2篇
  1977年   2篇
  1969年   2篇
  1965年   1篇
  1950年   2篇
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
101.
本研究通过方法学的改良和观察方式的创新试图阐明这种现象的原因.微卫星非传统的检测方法仅能实现微卫星定性检测,我所在的研究组开发了自动片段分析双荧光标识技术,提高了微卫星检测的感度和重复性,并实现了微卫星片段变化长度的定量.小于6碱基的微卫星变化被定义为修饰型微卫星不稳定,大于8碱基的变化被定义为跳跃型微卫星不稳定,它们的电泳谱截然不同.前者表现为在非肿瘤来源微卫星位点基础上的增加或减少,后者表现为距离非肿瘤微卫星片段远隔部位的新波形的出现.通过研究我们发现,在DNA错配修复缺陷细胞系及基因敲除大鼠自发肿瘤样本,仅有修饰型微卫星不稳定性检出;在人类DNA错配修复缺陷细胞系连续80次传代也没有检出跳跃型变化.跳跃型变化不能通过简单重复序列不稳定基础上的增加或减少的累加而获得.在76例散发大肠癌,我们检测了微卫星不稳定性,KRAS基因突变,并对高频度微卫星不稳定性病例的两个主要DNA错配修复基因MSH2和MLHl进行了全长测序.我们发现,在大肠癌,按频度的传统分类与按波形变化的分类有高度的一致性,高频度微卫星不稳定性病例均检测到跳跃型表现,低频度微卫星不稳定性都表现为修饰型变化.在12例高频度微卫星不稳定病例,有三例检出了跳跃型和修饰型同时存在微卫星不稳定的特殊表型,这3例均检出KRAS的突变,更有趣的是该3例病例也同时检出了DNA错配修复基因MLH1的变异.而在其他9例高频度微卫星不稳定病例,KRAS突变及MLH1、MSH2交变未检出.通过对突变谱的分析我们还发现,修饰型微卫星不稳定与KTAS基因12号密码子的转换型突变高度相关,而微卫星稳定的病例检出的KRAS基因12号密码子突变多为颠换型突变.修饰型微卫星不稳定表型检出的高频度转换突变可由DNA错配修复缺陷的分子背景解释.通过本研究,我们认为以波形为基础的微卫星不稳定新分型可能是解决目前微卫星研究领域矛盾的一个选项.一直公认为高频度微卫星不稳定性是"真正"的DNA错配修复缺陷表型,我们的研究提示实际上高频度微卫星的可能是多元的.修饰型微卫星不稳定与DNA错配修复缺陷直接关联,而跳跃型微卫星不稳定的原因尚未阐明.在高频度为微型不稳定中,携带修饰型变化的病例可以通过DNA错配修复系统缺陷来解释其病因.  相似文献   
102.
Apical membrane Ag 1 (AMA1) is a leading malaria vaccine candidate. Homologues of AMA1 can induce protection in mice and monkeys, but the mechanism of immunity is not understood. Mice immunized with a refolded, recombinant, Plasmodium chabaudi AMA1 fragment (AMA1B) can withstand subsequent challenge with P. chabaudi adami. Here we show that CD4+ T cell depletion, but not gammadelta T cell depletion, can cause a significant drop in antiparasite immunity in either immunized normal or immunized B cell KO mice. In normal mice, this loss of immunity is not accompanied by a decline in Ab levels. These observations indicate a role for AMA1-specific Ab-independent T cell-mediated immunity. However, the loss of immunity in normal CD4+ T cell-depleted mice is temporary. Furthermore, immunized B cell KO mice cannot survive infection, demonstrating the absolute importance of B cells, and presumably Ab, in AMA1-induced immunity. CD4+ T cells specific for a cryptic conserved epitope on AMA1 can adoptively transfer protection to athymic (nu/nu) mice, the level of which is enhanced by cotransfer of rabbit anti-AMA1-specific antisera. Recipients of rabbit antisera alone do not survive. Some protected recipients of T cells plus antisera do not develop their own AMA 1-specific Ab response, suggesting that AMA 1-specific CMI alone can protect mice. These data are the first to demonstrate the specificity of any protective CMI response in malaria and have important implications for developing a malaria vaccine.  相似文献   
103.
L Zhang  J Luo  M Hao  L Zhang  Z Yuan  Z Yan  Y Liu  B Zhang  B Liu  C Liu  H Zhang  Y Zheng  D Liu 《BMC genetics》2012,13(1):69-8
ABSTRACT: BACKGROUND: A synthetic doubled-haploid hexaploid wheat population, SynDH1, derived from the spontaneous chromosome doubling of triploid F1 hybrid plants obtained from the cross of hybrids Triticum turgidum ssp. durum line Langdon (LDN) and ssp. turgidum line AS313, with Aegilops tauschii ssp. tauschii accession AS60, was previously constructed. SynDH1 is a tetraploidization-hexaploid doubled haploid (DH) population because it contains recombinant A and B chromosomes from two different T. turgidum genotypes, while all the D chromosomes from Ae. tauschii are homogenous across the whole population. This paper reports the construction of a genetic map using this population. RESULTS: Of the 606 markers used to assemble the genetic map, 588 (97%) were assigned to linkage groups. These included 513 Diversity Arrays Technology (DArT) markers, 72 simple sequence repeat (SSR), one insertion site-based polymorphism (ISBP), and two high-molecular-weight glutenin subunit (HMW-GS) markers. These markers were assigned to the 14 chromosomes, covering 2048.79 cM, with a mean distance of 3.48 cM between adjacent markers. This map showed good coverage of the A and B genome chromosomes, apart from 3A, 5A, 6A, and 4B. Compared with previously reported maps, most shared markers showed highly consistent orders. This map was successfully used to identify five quantitative trait loci (QTL), including two for spikelet number on chromosomes 7A and 5B, two for spike length on 7A and 3B, and one for 1000-grain weight on 4B. However, differences in crossability QTL between the two T. turgidum parents may explain the segregation distortion regions on chromosomes 1A, 3B, and 6B. CONCLUSIONS: A genetic map of T. turgidum including 588 markers was constructed using a synthetic doubled haploid (SynDH) hexaploid wheat population. Five QTLs for three agronomic traits were identified from this population. However, more markers are needed to increase the density and resolution of this map in the future study.  相似文献   
104.
目的:使统计参数图软件(SPM)采用多种校正后的统计比较结果.方法:利用门限的方法,对三种结果的数值归类,采用多阈值进行分割,并利用彩色映射表,将三种结果彩显于同一平面图内.结果:三种结果分别以淡蓝、橙色和深红色显示于深蓝色参照图中.结论:该方法得到图像直观对比度好,且易实现,实用性较强.  相似文献   
105.
Heterocyclic ketones as inhibitors of histone deacetylase   总被引:1,自引:0,他引:1  
Several heterocyclic ketones were investigated as potential inhibitors of histone deacetylase. Nanomolar inhibitors such as 22 and 25 were obtained, the anti-proliferative activity of which were shown to be mediated by HDAC inhibition.  相似文献   
106.
极端酶的研究进展   总被引:5,自引:0,他引:5  
极端酶具有超常的生物学稳定性,能够在极端温度、pH、压力和离子强度下表现出生物学活性,因此极端酶为生物催化和生物转化提供了良机.新的极端物种的发现、基因组序列的确定及基因工程技术的应用,加快了发现和制备新酶的进程.蛋白质工程和定向进化技术进一步改善酶的活性和特异性,促进了极端酶的工业应用.对极端酶的研究加深了人们对酶稳定性机制的理解,丰富了分子进化理论.  相似文献   
107.
严艳  葛淼 《生物数学学报》2001,16(4):500-504
运用相关分析和回归分析的方法,研究了老年前期人红细胞压积参考值与地理因素的关系,结果表明海拔高度是影响红细胞压积参考值最主要的因素。  相似文献   
108.
高效降解棉酚菌株的选育及脱毒条件的研究   总被引:19,自引:0,他引:19  
From mildewed cottonseed cake and stock cultUres of mold and yeast We select more than ten strains of yeastS and molds which can degrade cotton Phenol. At last we got four strains which can degrade cotton phenol highly effeted after mutagenized by physical and chemical factors and induced by cotton Phenol. They belong to Candida tropicalis, Torulopsis candida, Aspergillus flavus and ASPergillus niger. By small and medium size fermenfations, the content of dissociated cottom Phenol all reach safe criterion (…  相似文献   
109.
Cellulose samples extracted from cornhusk have been successfully acetylated in an ionic liquid 1-allyl-3-methylimidazolium chloride (AmimCl). Without using any catalyst, cornhusk cellulose acetates (CCAs) with the degree of substitution (DS) in a range from 2.16 to 2.63 were prepared in one-step. Under the homogeneous state, the DS value of CCAs was easily controlled by the acetylation time. The obtained CCAs were characterized by means of FT-IR, 13C NMR, DSC, TGA, and a mechanical test. The NMR results showed that the distribution of the acetyl moiety among the three OH groups of the anhydroglucose unit shows a preference at the C6 position. The CCAs exhibited good solubility in some organic solvents, such as acetone and DMSO. The cast CCA films from their acetone solutions had good mechanical properties. At the end of each acetylation of cornhusk cellulose, the ionic liquid AmimCl could be effectively recovered. Therefore, this study presents a promising approach and “green process” to make use of crop by-products.  相似文献   
110.
随着分子生物学及基因工程技术的迅猛发展 ,基因治疗已经成为治疗人类疾病的重要方法之一 ,同时也是维护人类健康最有发展前景的手段之一。诸如遗传病、肿瘤、和传染病与心血管病的基因治疗。遗传免疫方面 ,病毒性疾病和肿瘤的基因治疗 ,如将病毒抗原基因 (HBsAg)及一些肿瘤抗原基因 (CEA)直接注入人体内而产生抗体 ;人类亚健康状态 ,如肥胖、秃顶、疲劳、衰老等的基因治疗。然而基因治疗目前仍面临着许多困扰 ,如基因治疗的有效性、安全性、及社会伦理等诸多问题 ,因此在临床实际应用中要慎之又慎。只有对基因治疗合理规范和正确引导并遵循伦理原则 ,才能最终推动现代医学的发展。  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号